Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer

NCT02281383 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
High Risk Superficial

Interventions

BIOLOGICAL: Bacillus Calmette-Guérin (BCG)

Sponsor

Memorial Sloan Kettering Cancer Center